Occurrence and resistance profile of bacteria belonging to the ESKAPE group in hemodialysis patients
DOI:
https://doi.org/10.26694/repis.v8i1.2248Palavras-chave:
Renal Insufficiency, Drug Resistance, Multiple, Cross Infection, Renal DialysisResumo
Introduction: Hemodialysis is the main treatment for patients with Chronic Renal Insufficiency and one of the main complications resulting from it is the occurrence of infections caused by opportunistic microorganisms belonging to the “ESKAPE” group. Aim: to determine the frequency of isolation of pathogens from the ESKAPE group and evaluate their respective antimicrobial resistance profiles in hemodialysis patients in a medium and high complexity hospital located in the Amazon. Outlining: Retrospective study carried out with collection of data available in the medical records of 167 patients diagnosed with Chronic Renal Insufficiency, undergoing hemodialysis or peritoneal dialysis from 2015 to 2019 in a regional hospital in the Southeast of Pará. Results: Of the 174 bacteriological cultures analyzed, 70.1% were positive and, of these, 57.4% were positive for bacteria belonging to the ESKAPE group. The most frequent microorganism belonging to the ESKAPE group was Staphylococcus aureus (47.1%); as to the resistance levels, 50% of Acinetobacter baumannii were resistant to carbapenems. Implications: The phenotypic profile of multidrug resistance to antimicrobials in strains of Acinetobacter baumannii was identified, highlighting the importance of knowledge about the profile of sensitivity to antimicrobials for a more assertive treatment and better prognosis.
Referências
Thomé FS, Sesso RC, Lopes AA, Lugon JR, Martins CT. Brazilian chronic dialysis. survey 2017. Brazilian J Nephrol. [Internet]. 2019 [cited 2022 Jul 01];41(2):208–14. http://dx.doi.org/10.1590/2175-8239-jbn-2018-0178
Sociedade Brasileira de Nefrologia. Dia mundial do Rim. São Paulo: SBN, 2020. Disponível em: https://www.sbn.org.br/
Sesso RC, Lopes AA, Thomé FS, Lugon JR, Martins CT. Brazilian Chronic Dialysis Census 2014. J Bras Nefrol. [Internet]. 2016 [cited 2022 Jul 01];38(1):54–61. http://dx.doi.org/10.5935/0101-2800.20160009
Mansur HN, Damasceno V de O, Bastos MG. Prevalencia de fragilidad entre los pacientes con efermedad renal crónica en tratamiento conservador y en diálisis. J Bras Nefrol. [Internet]. 2012 [cited 2022 Jul 01]34(2):153–60. doi: http://dx.doi.org/10.1590/S0101-28002012000200008
Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review. Front Microbiol. [Internet]. 2019 [cited 2022 Jul 01];10(1):539. https://doi.org/10.3389/fmicb.2019.00539
Silva DM, Menezes EMN, Silva EV., Lamounier TAC. Prevalence and antimicrobial susceptibility profile of ESKAPE pathogens from the Federal District, Brazil. J. Bras. Patol. Med. Lab. [Internet]. 2017 [cited 2022 Jul 01];53(4):240-245. https://doi.org/10.5935/1676-2444.20170037
Palacios M, Miner TA, Frederick DR, Sepulveda VE, Quinn JD, Walker KA, et al. Identification of Two Regulators of Virulence That Are Conserved in Klebsiella pneumoniae Classical and Hypervirulent Strains. Goldberg JB, editor. MBio. [Internet]. 2018 [cited 2022 Jul 01]; 9(4): e01443-18. https://doi.org/10.1128 / mBio.01443-18
Chavda KD, Chen L, Fouts DE, Sutton G, Brinkac L, Jenkins SG, et al. Comprehensive genome analysis of carbapenemase-producing Enterobacter spp.: New insights into phylogeny, population structure, and resistance mechanisms. MBio. [Internet]. 2016 [cited 2022 Jul 01];7(6):1-16. https://doi.org/10.1128/MBIO.02093-16
Castilho SRA, Godoy CSDM, Guilarde AO, Cardoso JL, André MCP, Junqueira-Kipnis AP, et al. Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles. Butaye P, editor. PLoS One. [Internet]. 2017 [cited 2022 Jul 01];12(5): e0176790. https://doi.org/10.1371/journal.pone.0176790
Mohamed H, Ali A, Browne LD, O’Connell NH, Casserly L, Stack AG, et al. Determinants and outcomes of access-related blood-stream infections among Irish haemodialysis patients; a cohort study. BMC Nephrol. [Internet]. 2019 [cited 2022 Jul 01];20(1):68. https://doi.org/10.1186/s12882-019-1253-x
Chu C, Wong MY, Tseng YH, Lin CL, Tung CW, Kao CC, et al. Vascular access infection by Staphylococcus aureus from removed dialysis accesses. Microbiologyopen. [Internet]. 2019 [cited 2022 Jul 01];8(8):1-10. https://doi.org/10.1002/mbo3.800
Nguyen DB, Shugart A, Lines C, Shah AB, Edwards J, Pollock D, et al. National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014. Clin J Am Soc Nephrol. [Internet]. 2017 [cited 2022 Jul 01];12(7):1139-46. https://doi.org/10.2215/CJN.11411116
Fysaraki M, Samonis G, Valachis A, Daphnis E, Karageorgopoulos DE, Falagas ME, et al. Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis. Int J Med Sci. [Internet]. 2013 [cited 2022 Jul 01];10(12):1632-8. https://doi.org/10.7150/ijms.6710
Song J-U, Park HK, Kang HK, Lee J. Proposed risk factors for infection with multidrug-resistant pathogens in hemodialysis patients hospitalized with pneumonia. BMC Infect Dis. [Internet]. 2017 [cited 2022 Jul 01];17(1) :681. https://doi.org/10.1186/s12879-017-2788-8
Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, et al. Antimicrobial Resistance in ESKAPE Pathogens. Clin Microbiol Rev. [Internet]. 2020[cited 2022 Jul 01];33(3):1–19. https://doi.org/10.1155/2016/2475067
AlAmri AM, AlQurayan AM, Sebastian T, AlNimr AM. Molecular Surveillance of Multidrug-Resistant Acinetobacter baumannii. Curr Microbiol. [Internet]. 2010 [cited 2022 Jul 01];77(3):335–42. https://doi.org/10.1007/s00284-019-01836-z
Silva KE, Maciel WG, Croda J, Cayô R, Ramos AC, de Sales RO, Kurihara MNL, Vasconcelos NG, Gales AC, Simionatto S. A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit. PLoS One. [Internet]. 2018 [cited 2022 Jul 01];13(12): e0209367. https://doi.org/10.1371/journal.pone.0209367
Zhou, H, Yao, Y, Zhu, B, Ren, D, Yang, Q, Fu, Y, Yu, Y, & Zhou, J. Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital. Medicine. [Internet]. 2019 [cited 2022 Jul 01];98(13), e14937. https://doi.org/10.1097/MD.0000000000014937
Ribeiro EA, Gales AC, Oliveira APS de, Coelho DD, Oliveira RA de, Pfrimer IAH, et al. Molecular epidemiology and drug resistance of Acinetobacter baumannii isolated from a regional hospital in the Brazilian Amazon region. Rev Soc Bras Med Trop. [Internet]. 2021 [cited 2022 Jul 01];54(1):e20200087. https://doi.org/10.1590/0037-8682-0087-2020
Snyder GM, Patel PR, Kallen AJ, Strom JA, Tucker JK, D'Agata EMC. Antimicrobial Use in Outpatient Hemodialysis Units. Infect Control Hosp Epidemiol [Internet]. 2013 [cited 2022 Jul 01];34(4):349–57. https://doi.org/10.1086/669869
Calfee DP. Multidrug-resistant organisms within the dialysis population: A potentially preventable perfect storm. Am J Kidney Dis. [Internet]. 2015 [cited 2022 Jul 01];65(1):3–5. https://doi.org/10.1053/j.ajkd.2014.10.003
Pop-Vicas A, Strom J, Stanley K, D'Agata EM. Multidrug-resistant Gram-negative bacteria among patients who require chronic hemodialysis. Clin J Am Soc Nephrol. [Internet]. 2008 [cited 2022 Jul 01];3(3):752-8. https://doi.org/10.2215/CJN.04651107
D’Agata EMC. Addressing the Problem of Multidrug-Resistant Organisms in Dialysis. Clin J Am Soc Nephrol [Internet]. 2018 [cited 2022 Jul 01]; 13(4):666-668. https://doi.org/10.2215/CJN.13781217
Chen Y, Liao K, Huang Y, Guo P, Huang H, Wu Z, et al. Determining the susceptibility of carbapenem resistant Klebsiella pneumoniae and Escherichia coli strains against common disinfectants at a tertiary hospital in China. BMC Infect Dis [Internet]. 2020 [cited 2022 Jul 01];20(1):88. https://doi.org/10.1186/s12879-020-4813-6
Vijayan A, Boyce JM. 100% use of infection control procedures in hemodialysis facilities: Call to action. Clin J Am Soc Nephrol [Internet]. 2018 [cited 2022 Jul 01];13(4):671-673. https://doi.org/10.2215/CJN.11341017
Collignon PJ, McEwen SA. One Health-Its Importance in Helping to Better Control Antimicrobial Resistance. Trop Med Infect Dis [Internet]. 2019 [cited 2022 Jul 01];4(1):22. https://doi.org/10.3390/tropicalmed4010022
